These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21971833)

  • 1. Stroke risk and NSAIDs: a systematic review of observational studies.
    Varas-Lorenzo C; Riera-Guardia N; Calingaert B; Castellsague J; Pariente A; Scotti L; Sturkenboom M; Perez-Gutthann S
    Pharmacoepidemiol Drug Saf; 2011 Dec; 20(12):1225-36. PubMed ID: 21971833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project).
    Castellsague J; Riera-Guardia N; Calingaert B; Varas-Lorenzo C; Fourrier-Reglat A; Nicotra F; Sturkenboom M; Perez-Gutthann S;
    Drug Saf; 2012 Dec; 35(12):1127-46. PubMed ID: 23137151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction.
    Hernández-Díaz S; Varas-Lorenzo C; García Rodríguez LA
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):266-74. PubMed ID: 16611201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonaspirin Nonsteroidal Anti-Inflammatory Drugs and Risk of Hemorrhagic Stroke: A Systematic Review and Meta-Analysis of Observational Studies.
    Ungprasert P; Matteson EL; Thongprayoon C
    Stroke; 2016 Feb; 47(2):356-64. PubMed ID: 26670086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial infarction and individual nonsteroidal anti-inflammatory drugs meta-analysis of observational studies.
    Varas-Lorenzo C; Riera-Guardia N; Calingaert B; Castellsague J; Salvo F; Nicotra F; Sturkenboom M; Perez-Gutthann S
    Pharmacoepidemiol Drug Saf; 2013 Jun; 22(6):559-70. PubMed ID: 23616423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular safety of lumiracoxib: a meta-analysis of all randomized controlled trials > or =1 week and up to 1 year in duration of patients with osteoarthritis and rheumatoid arthritis.
    Matchaba P; Gitton X; Krammer G; Ehrsam E; Sloan VS; Olson M; Mellein B; Hoexter G; Orloff J; Garaud JJ
    Clin Ther; 2005 Aug; 27(8):1196-214. PubMed ID: 16199245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.
    McGettigan P; Henry D
    JAMA; 2006 Oct; 296(13):1633-44. PubMed ID: 16968831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies.
    McGettigan P; Henry D
    PLoS Med; 2011 Sep; 8(9):e1001098. PubMed ID: 21980265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-steroidal anti-inflammatory drug-induced cardiovascular adverse events: a meta-analysis.
    Gunter BR; Butler KA; Wallace RL; Smith SM; Harirforoosh S
    J Clin Pharm Ther; 2017 Feb; 42(1):27-38. PubMed ID: 28019014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease.
    Roumie CL; Choma NN; Kaltenbach L; Mitchel EF; Arbogast PG; Griffin MR
    Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1053-63. PubMed ID: 19637402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual non-steroidal anti-inflammatory drugs and risk of acute kidney injury: A systematic review and meta-analysis of observational studies.
    Ungprasert P; Cheungpasitporn W; Crowson CS; Matteson EL
    Eur J Intern Med; 2015 May; 26(4):285-91. PubMed ID: 25862494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding.
    Massó González EL; Patrignani P; Tacconelli S; García Rodríguez LA
    Arthritis Rheum; 2010 Jun; 62(6):1592-601. PubMed ID: 20178131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular Risk of Nonsteroidal Anti-inflammatory Drugs and Classical and Selective Cyclooxygenase-2 Inhibitors: A Meta-analysis of Observational Studies.
    Martín Arias LH; Martín González A; Sanz Fadrique R; Vazquez ES
    J Clin Pharmacol; 2019 Jan; 59(1):55-73. PubMed ID: 30204233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.
    Solomon DH; Avorn J; Stürmer T; Glynn RJ; Mogun H; Schneeweiss S
    Arthritis Rheum; 2006 May; 54(5):1378-89. PubMed ID: 16645966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Hemorrhagic Stroke in Patients Exposed to Nonsteroidal Anti-Inflammatory Drugs: A Meta-Analysis of Observational Studies.
    Islam MM; Poly TN; Walther BA; Yang HC; Lin MC; Li YC
    Neuroepidemiology; 2018; 51(3-4):166-176. PubMed ID: 30153662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs and risk of stroke.
    Haag MD; Bos MJ; Hofman A; Koudstaal PJ; Breteler MM; Stricker BH
    Arch Intern Med; 2008 Jun; 168(11):1219-24. PubMed ID: 18541831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonaspirin NSAIDs, cyclooxygenase 2 inhibitors, and the risk for stroke.
    Roumie CL; Mitchel EF; Kaltenbach L; Arbogast PG; Gideon P; Griffin MR
    Stroke; 2008 Jul; 39(7):2037-45. PubMed ID: 18436878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and the risk of ischemic stroke: a nested case-control study.
    Andersohn F; Schade R; Suissa S; Garbe E
    Stroke; 2006 Jul; 37(7):1725-30. PubMed ID: 16728684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk of selective cyclooxygenase-2 inhibitors and other non-aspirin non-steroidal anti-inflammatory medications.
    Velentgas P; West W; Cannuscio CC; Watson DJ; Walker AM
    Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):641-52. PubMed ID: 16392153
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.